On 2026-07-13, Lexaria Bioscience Corp. (LEXX) announced earnings per share of $-1.20 for the fiscal quarter ending 2026-05-31, missing the average analyst estimate of $-0.90.
The next expected annoucement date for quarterly earnings is 2026-11-25, with an average estimated earnings per share of $-0.90 for the fiscal quarter ending 2026-08-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-07-13 | 2026-05-31 | $-0.90 | $-1.20 |
| 2026-04-13 | 2026-02-28 | $-1.50 | $-0.90 |
| 2026-01-13 | 2025-11-30 | $-1.95 | $-1.05 |
| 2025-11-26 | 2025-08-31 | $-2.40 | $-1.95 |
| 2025-07-14 | 2025-05-31 | $-2.25 | $-3.15 |
| 2025-04-14 | 2025-02-28 | $-2.40 | $-2.25 |
| 2025-01-10 | 2024-11-30 | $-1.80 | $-2.40 |
| 2024-11-26 | 2024-08-31 | $-1.65 | $-2.25 |
| 2024-07-12 | 2024-05-31 | $-1.35 | $-1.95 |
| 2024-04-09 | 2024-02-29 | -- | $-0.90 |
| 2024-01-12 | 2023-11-30 | -- | $-1.95 |
| 2023-11-21 | 2023-08-31 | $-2.55 | $-1.80 |
| 2023-07-14 | 2023-05-31 | $-3.75 | $-5.55 |
| 2023-04-14 | 2023-02-28 | -- | $-3.30 |
| 2023-01-17 | 2022-11-30 | -- | $-4.50 |
| 2022-11-25 | 2022-08-31 | -- | $-3.60 |
| 2022-07-14 | 2022-05-31 | $-4.20 | $-6.15 |
| 2022-04-11 | 2022-02-28 | $-3.15 | $-3.75 |
| 2022-01-14 | 2021-11-30 | -- | $-5.25 |
| 2021-07-15 | 2021-05-31 | -- | $-6.00 |
| 2021-04-14 | 2021-02-28 | -- | $-4.20 |
| 2021-01-14 | 2020-11-30 | -- | $-3.60 |
| 2020-10-14 | 2020-08-31 | -- | $-4.50 |